{"transactions":[{"id":505,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-02T20:16:37.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":644,"price":9.7,"value":6246.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500."}],"balance_after":1340419,"source":{"system":"sec-edgar","filing":"0000882796-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385496/000088279626000065/form4.xml","form_type":"4"}},{"id":445,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":410,"kind":"person","name":"Milne Jill C.","position":1,"cik":"0001644246","reported_name":"Milne Jill C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-02T20:13:09.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":1288,"price":9.7,"value":12493.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $12,500."}],"balance_after":33226,"source":{"system":"sec-edgar","filing":"0000882796-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644246/000088279626000063/form4.xml","form_type":"4"}},{"id":423,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-02T20:10:23.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":9.7,"value":11242.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Chair retainer of $22,500."}],"balance_after":109642,"source":{"system":"sec-edgar","filing":"0000882796-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187159/000088279626000061/form4.xml","form_type":"4"}},{"id":372,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-02T20:06:56.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":644,"price":9.7,"value":6246.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500."}],"balance_after":47821,"source":{"system":"sec-edgar","filing":"0000882796-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1883764/000088279626000059/form4.xml","form_type":"4"}},{"id":332,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":316,"kind":"person","name":"Frank Steven","position":1,"cik":"0001583886","reported_name":"Frank Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-02T20:04:37.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":1288,"price":9.7,"value":12493.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $12,500."}],"balance_after":36747,"source":{"system":"sec-edgar","filing":"0000882796-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583886/000088279626000057/form4.xml","form_type":"4"}},{"id":738610,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":410,"kind":"person","name":"Milne Jill C.","position":1,"cik":"0001644246","reported_name":"Milne Jill C.","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:32:01.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000055/form4.xml","form_type":"4"}},{"id":738609,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":410,"kind":"person","name":"Milne Jill C.","position":1,"cik":"0001644246","reported_name":"Milne Jill C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:32:01.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":31938,"source":{"system":"sec-edgar","filing":"0000882796-26-000055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000055/form4.xml","form_type":"4"}},{"id":738608,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:30:38.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000053/form4.xml","form_type":"4"}},{"id":738607,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38385,"kind":"person","name":"Galson Steven K","position":1,"cik":"0001495328","reported_name":"Galson Steven K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:30:38.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":27794,"source":{"system":"sec-edgar","filing":"0000882796-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000053/form4.xml","form_type":"4"}},{"id":738604,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":17250,"kind":"person","name":"LEVIN ALAN G","position":1,"cik":"0001174452","reported_name":"LEVIN ALAN G","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:29:22.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000052/form4.xml","form_type":"4"}},{"id":738603,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":17250,"kind":"person","name":"LEVIN ALAN G","position":1,"cik":"0001174452","reported_name":"LEVIN ALAN G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:29:22.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":79565,"source":{"system":"sec-edgar","filing":"0000882796-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000052/form4.xml","form_type":"4"}},{"id":738606,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":316,"kind":"person","name":"Frank Steven","position":1,"cik":"0001583886","reported_name":"Frank Steven","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:16:15.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000045","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000045/form4.xml","form_type":"4"}},{"id":738605,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":316,"kind":"person","name":"Frank Steven","position":1,"cik":"0001583886","reported_name":"Frank Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:16:15.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":35459,"source":{"system":"sec-edgar","filing":"0000882796-26-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000045/form4.xml","form_type":"4"}},{"id":738602,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:14:41.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000043","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000043/form4.xml","form_type":"4"}},{"id":738601,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:14:41.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":45936,"source":{"system":"sec-edgar","filing":"0000882796-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000043/form4.xml","form_type":"4"}},{"id":738600,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:12:06.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000041/form4.xml","form_type":"4"}},{"id":738599,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:12:06.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":108483,"source":{"system":"sec-edgar","filing":"0000882796-26-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000041/form4.xml","form_type":"4"}},{"id":738598,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:10:23.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000039/form4.xml","form_type":"4"}},{"id":738597,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:10:23.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":1339775,"source":{"system":"sec-edgar","filing":"0000882796-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000039/form4.xml","form_type":"4"}},{"id":738594,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:08:27.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000037/form4.xml","form_type":"4"}},{"id":738593,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:08:27.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":47177,"source":{"system":"sec-edgar","filing":"0000882796-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000037/form4.xml","form_type":"4"}},{"id":738596,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:06:08.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000035/form4.xml","form_type":"4"}},{"id":738595,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:06:08.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":80646,"source":{"system":"sec-edgar","filing":"0000882796-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000035/form4.xml","form_type":"4"}},{"id":756039,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":410,"kind":"person","name":"Milne Jill C.","position":1,"cik":"0001644246","reported_name":"Milne Jill C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T20:16:22.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":1262,"price":8.91,"value":11244.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":16644,"source":{"system":"sec-edgar","filing":"0000882796-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000033/form4.xml","form_type":"4"}},{"id":756036,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T20:14:06.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":631,"price":8.91,"value":5622.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":1324481,"source":{"system":"sec-edgar","filing":"0000882796-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000031/form4.xml","form_type":"4"}},{"id":756035,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T20:11:14.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":631,"price":8.91,"value":5622.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":31883,"source":{"system":"sec-edgar","filing":"0000882796-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000029/form4.xml","form_type":"4"}},{"id":756034,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T20:08:44.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":1122,"price":8.91,"value":9997.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Chair retainer of $20,000."}],"balance_after":93189,"source":{"system":"sec-edgar","filing":"0000882796-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000027/form4.xml","form_type":"4"}},{"id":756033,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":316,"kind":"person","name":"Frank Steven","position":1,"cik":"0001583886","reported_name":"Frank Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T20:05:57.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":1262,"price":8.91,"value":11244.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":20165,"source":{"system":"sec-edgar","filing":"0000882796-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000025/form4.xml","form_type":"4"}},{"id":773422,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-19T20:07:43.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":11180,"price":8.97,"value":100284.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.96 to $8.985. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":31252,"source":{"system":"sec-edgar","filing":"0000882796-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000023/form4.xml","form_type":"4"}},{"id":777896,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2026-05-15T20:08:01.000Z","date":"2026-05-13","kind":"exercise","planned":true,"acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant became exercisable at the rate of 25% on each of the first, second, third, and fourth anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":5.04,"exercise_date":"2018-12-20","expiration_date":"2027-12-20","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000882796-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000021/form4.xml","form_type":"4"}},{"id":777895,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-15T20:08:01.000Z","date":"2026-05-13","kind":"sale","planned":true,"acquired":false,"shares":62500,"price":9.54,"value":596250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":400703,"source":{"system":"sec-edgar","filing":"0000882796-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000021/form4.xml","form_type":"4"}},{"id":777894,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-15T20:08:01.000Z","date":"2026-05-13","kind":"exercise","planned":true,"acquired":true,"shares":62500,"price":5.04,"value":315000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":463203,"source":{"system":"sec-edgar","filing":"0000882796-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000021/form4.xml","form_type":"4"}},{"id":813876,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":53505,"kind":"person","name":"Menon Sandeep","position":1,"cik":"0002123967","reported_name":"Menon Sandeep","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2026-04-07T20:24:44.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":441350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":441350,"derivative":{"exercise_price":9.47,"expiration_date":"2036-04-06","underlying":"Common Stock","underlying_shares":441350},"source":{"system":"sec-edgar","filing":"0000882796-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000019/form4.xml","form_type":"4"}},{"id":813875,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":53505,"kind":"person","name":"Menon Sandeep","position":1,"cik":"0002123967","reported_name":"Menon Sandeep","relationship":{"officer":true,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-04-07T20:24:44.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":205150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the \"Stock Incentive Plan\"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":205150,"source":{"system":"sec-edgar","filing":"0000882796-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000019/form4.xml","form_type":"4"}},{"id":830005,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-03-24T20:02:35.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":49933,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.3,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":49933},"source":{"system":"sec-edgar","filing":"0000882796-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000017/form4.xml","form_type":"4"}},{"id":830004,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-24T20:02:35.000Z","date":"2026-03-20","kind":"sale","planned":false,"acquired":false,"shares":49933,"price":10.11,"value":504822.63,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.09 to $10.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":65352,"source":{"system":"sec-edgar","filing":"0000882796-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000017/form4.xml","form_type":"4"}},{"id":830003,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-24T20:02:35.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":49933,"price":6.3,"value":314577.9,"ownership":{"direct":true},"balance_after":115285,"source":{"system":"sec-edgar","filing":"0000882796-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000017/form4.xml","form_type":"4"}},{"id":835913,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2026-03-18T20:11:09.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant became exercisable at the rate of 25% on each of the first, second, third, and fourth anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":5.51,"exercise_date":"2018-02-27","expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000882796-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000015/form4.xml","form_type":"4"}},{"id":835912,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:11:09.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":150000,"price":9.15,"value":1372500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.95 to $9.57. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":400703,"source":{"system":"sec-edgar","filing":"0000882796-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000015/form4.xml","form_type":"4"}},{"id":835911,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:11:09.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":150000,"price":5.51,"value":826500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":550703,"source":{"system":"sec-edgar","filing":"0000882796-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000015/form4.xml","form_type":"4"}},{"id":871222,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":410,"kind":"person","name":"Milne Jill C.","position":1,"cik":"0001644246","reported_name":"Milne Jill C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:36:58.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":528,"price":8.75,"value":4620.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 100% of the prorated quarterly cash Board Member retainer of $4,625."}],"balance_after":15382,"source":{"system":"sec-edgar","filing":"0000882796-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000013/form4.xml","form_type":"4"}},{"id":871221,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2026-03-03T21:34:13.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":305995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 28, 2022, as modified on May 13, 2024 and further modified on May 29, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The options were originally granted to the reporting person on May 23, 2016 and would have expired on May 23, 2026. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":0,"derivative":{"exercise_price":3.22,"exercise_date":"2017-05-23","expiration_date":"2026-05-23","underlying":"Common Stock","underlying_shares":305995},"source":{"system":"sec-edgar","filing":"0000882796-26-000011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000011/form4.xml","form_type":"4"}},{"id":871220,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:34:13.000Z","date":"2026-03-02","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":305995,"price":8.64,"value":2643796.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 28, 2022, as modified on May 13, 2024 and further modified on May 29, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The options were originally granted to the reporting person on May 23, 2016 and would have expired on May 23, 2026. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.54 to $8.81. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":1323850,"source":{"system":"sec-edgar","filing":"0000882796-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000011/form4.xml","form_type":"4"}},{"id":871219,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:34:13.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":305995,"price":3.22,"value":985303.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 28, 2022, as modified on May 13, 2024 and further modified on May 29, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The options were originally granted to the reporting person on May 23, 2016 and would have expired on May 23, 2026. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":1629845,"source":{"system":"sec-edgar","filing":"0000882796-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000011/form4.xml","form_type":"4"}},{"id":871218,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:34:13.000Z","date":"2026-02-27","kind":"grant","planned":true,"acquired":true,"shares":421,"price":8.75,"value":3683.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the prorated quarterly cash Board Member retainer of $7,375."}],"balance_after":1323850,"source":{"system":"sec-edgar","filing":"0000882796-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000011/form4.xml","form_type":"4"}},{"id":871217,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:30:55.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":848,"price":8.75,"value":7420.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250 and, effective January 23, 2026, in lieu of 50% of the quarterly cash Board Chair retainer of $20,000."}],"balance_after":92067,"source":{"system":"sec-edgar","filing":"0000882796-26-000009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000009/form4.xml","form_type":"4"}},{"id":871216,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":316,"kind":"person","name":"Frank Steven","position":1,"cik":"0001583886","reported_name":"Frank Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:29:17.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":1285,"price":8.75,"value":11243.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":18903,"source":{"system":"sec-edgar","filing":"0000882796-26-000007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000007/form4.xml","form_type":"4"}},{"id":871215,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:25:59.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":642,"price":8.75,"value":5617.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":42432,"source":{"system":"sec-edgar","filing":"0000882796-26-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000005/form4.xml","form_type":"4"}},{"id":930518,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":410,"kind":"person","name":"Milne Jill C.","position":1,"cik":"0001644246","reported_name":"Milne Jill C.","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-01-27T22:22:33.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":26684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vests 1/36 per month over a 3-year period measured from the date of grant."}],"balance_after":26684,"derivative":{"exercise_price":6.79,"expiration_date":"2036-01-23","underlying":"Common Stock","underlying_shares":26684},"source":{"system":"sec-edgar","filing":"0000882796-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000003/form4.xml","form_type":"4"}},{"id":930517,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":410,"kind":"person","name":"Milne Jill C.","position":1,"cik":"0001644246","reported_name":"Milne Jill C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-27T22:22:33.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":12272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Automatic non-employee director grant of restricted stock units pursuant to the BioCryst Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest in three equal annual installments beginning on the twelve-month anniversary of the date of grant."}],"balance_after":14854,"source":{"system":"sec-edgar","filing":"0000882796-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000003/form4.xml","form_type":"4"}},{"id":930516,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":410,"kind":"person","name":"Milne Jill C.","position":1,"cik":"0001644246","reported_name":"Milne Jill C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-27T22:22:33.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":2582,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 4,377 shares of Astria Therapeutics, Inc. (\"Astria\") common stock in connection with a merger (the \"Merger\"), pursuant to which Astria became a wholly owned subsidiary of BioCryst Pharmaceuticals, Inc. (\"BioCryst\"). Pursuant to the Merger, each share of Astria common stock (subject to certain inapplicable exceptions) was converted into the right to receive (i) 0.59 of a share of common stock of BioCryst and, if applicable, cash in lieu of fractional shares, and (ii) $8.55 in cash, without interest, subject to applicable withholding taxes. On the last trading day before the effective date of the Merger, the closing price of Astria's common stock was $12.58 per share, and the closing price of BioCryst's common stock was $6.75 per share."}],"balance_after":2582,"source":{"system":"sec-edgar","filing":"0000882796-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000003/form4.xml","form_type":"4"}},{"id":960282,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:13:58.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":61793,"price":7.41,"value":457886.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person."}],"balance_after":1323429,"source":{"system":"sec-edgar","filing":"0000882796-25-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000045/form4.xml","form_type":"4"}},{"id":960273,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:11:38.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":21773,"price":7.65,"value":166563.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":398751,"source":{"system":"sec-edgar","filing":"0000882796-25-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000043/form4.xml","form_type":"4"}},{"id":960272,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:11:38.000Z","date":"2025-12-19","kind":"tax_withholding","planned":true,"acquired":false,"shares":16902,"price":7.41,"value":125243.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person."}],"balance_after":420524,"source":{"system":"sec-edgar","filing":"0000882796-25-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000043/form4.xml","form_type":"4"}},{"id":960271,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"officer":true,"officer_title":"President and CCO"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-12-23T21:08:40.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant became exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":5.51,"exercise_date":"2018-02-27","expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000882796-25-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000041/form4.xml","form_type":"4"}},{"id":960270,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"officer":true,"officer_title":"President and CCO"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-12-23T21:08:40.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":false,"shares":10091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant became exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":17409,"derivative":{"exercise_price":5.04,"exercise_date":"2018-12-20","expiration_date":"2027-12-20","underlying":"Common Stock","underlying_shares":10091},"source":{"system":"sec-edgar","filing":"0000882796-25-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000041/form4.xml","form_type":"4"}},{"id":960269,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"officer":true,"officer_title":"President and CCO"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-12-23T21:08:40.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":false,"shares":14142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant became exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":3.22,"exercise_date":"2017-05-23","expiration_date":"2026-05-23","underlying":"Common Stock","underlying_shares":14142},"source":{"system":"sec-edgar","filing":"0000882796-25-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000041/form4.xml","form_type":"4"}},{"id":960268,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"officer":true,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2025-12-23T21:08:40.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"balance_after":952583,"source":{"system":"sec-edgar","filing":"0000882796-25-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000041/form4.xml","form_type":"4"}},{"id":960267,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"officer":true,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2025-12-23T21:08:40.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":true,"shares":10091,"price":5.04,"value":50858.64,"ownership":{"direct":true},"balance_after":902583,"source":{"system":"sec-edgar","filing":"0000882796-25-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000041/form4.xml","form_type":"4"}},{"id":960266,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"officer":true,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2025-12-23T21:08:40.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":true,"shares":14142,"price":3.22,"value":45537.24,"ownership":{"direct":true},"balance_after":892492,"source":{"system":"sec-edgar","filing":"0000882796-25-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000041/form4.xml","form_type":"4"}},{"id":960265,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"officer":true,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2025-12-23T21:08:40.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":11477,"price":7.41,"value":85044.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person."}],"balance_after":878350,"source":{"system":"sec-edgar","filing":"0000882796-25-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000041/form4.xml","form_type":"4"}},{"id":962581,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:21:58.000Z","date":"2025-12-18","kind":"gift","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2025, the reporting person gifted 10,000 shares held directly by him to each of the Caroline Stonehouse Irrevocable Trust and the Samuel Stonehouse Irrevocable Trust."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001171843-25-008039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325008039/ownership.xml","form_type":"4"}},{"id":962580,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:21:58.000Z","date":"2025-12-18","kind":"gift","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2025, the reporting person gifted 10,000 shares held directly by him to each of the Caroline Stonehouse Irrevocable Trust and the Samuel Stonehouse Irrevocable Trust."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001171843-25-008039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325008039/ownership.xml","form_type":"4"}},{"id":962579,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:21:58.000Z","date":"2025-12-18","kind":"gift","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2025, the reporting person gifted 10,000 shares held directly by him to each of the Caroline Stonehouse Irrevocable Trust and the Samuel Stonehouse Irrevocable Trust."}],"balance_after":1385222,"source":{"system":"sec-edgar","filing":"0001171843-25-008039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325008039/ownership.xml","form_type":"4"}},{"id":962578,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CCO"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-12-19T21:20:44.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":986950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":986950,"derivative":{"exercise_price":7.13,"exercise_date":"2026-12-17","expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":986950},"source":{"system":"sec-edgar","filing":"0001171843-25-008038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325008038/ownership.xml","form_type":"4"}},{"id":962577,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2025-12-19T21:20:44.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":471000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":889827,"source":{"system":"sec-edgar","filing":"0001171843-25-008038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325008038/ownership.xml","form_type":"4"}},{"id":962574,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-12-19T21:17:34.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":255050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":255050,"derivative":{"exercise_price":7.13,"exercise_date":"2026-12-17","expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":255050},"source":{"system":"sec-edgar","filing":"0001171843-25-008037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325008037/ownership.xml","form_type":"4"}},{"id":962573,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:17:34.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":121700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":437426,"source":{"system":"sec-edgar","filing":"0001171843-25-008037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325008037/ownership.xml","form_type":"4"}},{"id":962576,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":71140,"kind":"person","name":"Ghias Babar","position":1,"cik":"0002076862","reported_name":"Ghias Babar","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-12-19T21:11:18.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":355050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":355050,"derivative":{"exercise_price":7.13,"exercise_date":"2026-12-17","expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":355050},"source":{"system":"sec-edgar","filing":"0000882796-25-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000038/form4.xml","form_type":"4"}},{"id":962575,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":71140,"kind":"person","name":"Ghias Babar","position":1,"cik":"0002076862","reported_name":"Ghias Babar","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:11:18.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":121700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":268700,"source":{"system":"sec-edgar","filing":"0000882796-25-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000038/form4.xml","form_type":"4"}},{"id":968339,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":70918,"kind":"person","name":"Gayer Charles K","position":1,"cik":"0001800110","reported_name":"Gayer Charles K","relationship":{"officer":true,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2025-12-16T21:21:18.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":8181,"price":7.57,"value":61930.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person."}],"balance_after":418827,"source":{"system":"sec-edgar","filing":"0000882796-25-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000036/form4.xml","form_type":"4"}},{"id":968341,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-16T21:13:10.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":21210,"price":7.65,"value":162256.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":315726,"source":{"system":"sec-edgar","filing":"0000882796-25-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000033/form4.xml","form_type":"4"}},{"id":968340,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-16T21:13:10.000Z","date":"2025-12-12","kind":"tax_withholding","planned":true,"acquired":false,"shares":8540,"price":7.57,"value":64647.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person."}],"balance_after":336936,"source":{"system":"sec-edgar","filing":"0000882796-25-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000033/form4.xml","form_type":"4"}},{"id":968338,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":471,"kind":"person","name":"Stonehouse Jon P","position":1,"cik":"0001385496","reported_name":"Stonehouse Jon P","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-16T21:09:05.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":27368,"price":7.57,"value":207175.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person."}],"balance_after":1405222,"source":{"system":"sec-edgar","filing":"0000882796-25-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000031/form4.xml","form_type":"4"}},{"id":982626,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-12-03T23:40:53.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":false,"shares":91004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant became exercisable at the rate of 25.0% on each of the first, second, third, and fourth anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":3.22,"exercise_date":"2017-05-23","expiration_date":"2026-05-23","underlying":"Common Stock","underlying_shares":91004},"source":{"system":"sec-edgar","filing":"0000882796-25-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000027/form4.xml","form_type":"4"}},{"id":982625,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-03T23:40:53.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":19770,"price":7.65,"value":151240.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":345476,"source":{"system":"sec-edgar","filing":"0000882796-25-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000027/form4.xml","form_type":"4"}},{"id":982624,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-03T23:40:53.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":50906,"price":7.2136,"value":367215.5216,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.180 to $7.255. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":365246,"source":{"system":"sec-edgar","filing":"0000882796-25-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000027/form4.xml","form_type":"4"}},{"id":982623,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-03T23:40:53.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":91004,"price":7.1042,"value":646510.6168,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.015 to $7.190. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":416152,"source":{"system":"sec-edgar","filing":"0000882796-25-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000027/form4.xml","form_type":"4"}},{"id":982622,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":47066,"kind":"person","name":"Barnes Alane P","position":1,"cik":"0001584348","reported_name":"Barnes Alane P","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-03T23:40:53.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":true,"shares":91004,"price":3.22,"value":293032.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":507156,"source":{"system":"sec-edgar","filing":"0000882796-25-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000027/form4.xml","form_type":"4"}},{"id":984289,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-02T21:14:11.000Z","date":"2025-11-28","kind":"grant","planned":false,"acquired":true,"shares":783,"price":7.18,"value":5621.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":41790,"source":{"system":"sec-edgar","filing":"0000882796-25-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000023/form4.xml","form_type":"4"}},{"id":984290,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":316,"kind":"person","name":"Frank Steven","position":1,"cik":"0001583886","reported_name":"Frank Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-02T21:10:21.000Z","date":"2025-11-28","kind":"grant","planned":false,"acquired":true,"shares":1566,"price":7.18,"value":11243.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":17618,"source":{"system":"sec-edgar","filing":"0000882796-25-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000021/form4.xml","form_type":"4"}},{"id":984288,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-02T21:07:27.000Z","date":"2025-11-28","kind":"grant","planned":false,"acquired":true,"shares":783,"price":7.18,"value":5621.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":91219,"source":{"system":"sec-edgar","filing":"0000882796-25-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000019/form4.xml","form_type":"4"}},{"id":998318,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-17T21:07:08.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":9600,"price":7.14,"value":68544.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a plan adopted by the Reporting Person on August 14, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale occurred automatically and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":30642,"source":{"system":"sec-edgar","filing":"0000882796-25-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000017/form4.xml","form_type":"4"}},{"id":1050644,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-09-03T20:30:01.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":676,"price":8.31,"value":5617.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":41007,"source":{"system":"sec-edgar","filing":"0000882796-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000013/form4.xml","form_type":"4"}},{"id":1050643,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":316,"kind":"person","name":"Frank Steven","position":1,"cik":"0001583886","reported_name":"Frank Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-09-03T20:07:34.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":1353,"price":8.31,"value":11243.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":16052,"source":{"system":"sec-edgar","filing":"0000882796-25-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000005/form4.xml","form_type":"4"}},{"id":1050639,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-09-03T20:04:50.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":676,"price":8.31,"value":5617.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":90436,"source":{"system":"sec-edgar","filing":"0000882796-25-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000003/form4.xml","form_type":"4"}},{"id":1065905,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2025-08-15T12:24:54.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.41,"exercise_date":"2021-05-12","expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001127602-25-020491","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225020491/form4.xml","form_type":"4"}},{"id":1065904,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2025-08-15T12:24:54.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.91,"exercise_date":"2020-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001127602-25-020491","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225020491/form4.xml","form_type":"4"}},{"id":1065903,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-15T12:24:54.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":70000,"price":8.5124,"value":595868.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.48 to $8.55. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":65352,"source":{"system":"sec-edgar","filing":"0001127602-25-020491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225020491/form4.xml","form_type":"4"}},{"id":1065902,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-15T12:24:54.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":5.41,"value":216400.0,"ownership":{"direct":true},"balance_after":135352,"source":{"system":"sec-edgar","filing":"0001127602-25-020491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225020491/form4.xml","form_type":"4"}},{"id":1065901,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":38384,"kind":"person","name":"HEGGIE THERESA","position":1,"cik":"0001760020","reported_name":"HEGGIE THERESA","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-15T12:24:54.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":2.91,"value":87300.0,"ownership":{"direct":true},"balance_after":95352,"source":{"system":"sec-edgar","filing":"0001127602-25-020491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225020491/form4.xml","form_type":"4"}},{"id":1081020,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":71140,"kind":"person","name":"Ghias Babar","position":1,"cik":"0002076862","reported_name":"Ghias Babar","relationship":{"officer":true,"officer_title":"CFO & Head of Corp Development"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-07-28T20:09:44.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":305000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":305000,"derivative":{"exercise_price":8.55,"exercise_date":"2026-07-24","expiration_date":"2035-07-24","underlying":"Common Stock","underlying_shares":305000},"source":{"system":"sec-edgar","filing":"0001127602-25-019632","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225019632/form4.xml","form_type":"4"}},{"id":1081019,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":71140,"kind":"person","name":"Ghias Babar","position":1,"cik":"0002076862","reported_name":"Ghias Babar","relationship":{"officer":true,"officer_title":"CFO & Head of Corp Development"}}],"security":"Common Stock","published_at":"2025-07-28T20:09:44.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":147000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the \"Stock Incentive Plan\"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":147000,"source":{"system":"sec-edgar","filing":"0001127602-25-019632","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225019632/form4.xml","form_type":"4"}},{"id":1110482,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Automatic Stock Option Grant","published_at":"2025-06-16T20:22:22.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":27181,"derivative":{"exercise_price":10.4,"exercise_date":"2026-06-12","expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":27181},"source":{"system":"sec-edgar","filing":"0001171843-25-003918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003918/ownership.xml","form_type":"4"}},{"id":1110481,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":26251,"kind":"person","name":"SANDERS MACHELLE","position":1,"cik":"0001718020","reported_name":"SANDERS MACHELLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:22:22.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":40242,"source":{"system":"sec-edgar","filing":"0001171843-25-003918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003918/ownership.xml","form_type":"4"}},{"id":1110484,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Automatic Stock Option Grant","published_at":"2025-06-16T20:21:59.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":27181,"derivative":{"exercise_price":10.4,"exercise_date":"2026-06-12","expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":27181},"source":{"system":"sec-edgar","filing":"0001171843-25-003917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003917/ownership.xml","form_type":"4"}},{"id":1110483,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":391,"kind":"person","name":"MILANO VINCENT","position":1,"cik":"0001187159","reported_name":"MILANO VINCENT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:21:59.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":89760,"source":{"system":"sec-edgar","filing":"0001171843-25-003917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003917/ownership.xml","form_type":"4"}},{"id":1110480,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Automatic Stock Option Grant","published_at":"2025-06-16T20:21:36.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":27181,"derivative":{"exercise_price":10.4,"exercise_date":"2026-06-12","expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":27181},"source":{"system":"sec-edgar","filing":"0001171843-25-003916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003916/ownership.xml","form_type":"4"}},{"id":1110479,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:21:36.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":40331,"source":{"system":"sec-edgar","filing":"0001171843-25-003916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003916/ownership.xml","form_type":"4"}},{"id":1110476,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":17250,"kind":"person","name":"LEVIN ALAN G","position":1,"cik":"0001174452","reported_name":"LEVIN ALAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Automatic Stock Option Grant","published_at":"2025-06-16T20:21:00.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":27181,"derivative":{"exercise_price":10.4,"exercise_date":"2026-06-12","expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":27181},"source":{"system":"sec-edgar","filing":"0001171843-25-003915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003915/ownership.xml","form_type":"4"}}],"next_cursor":"2025-06-16T20:21:00.000000Z,1110476"}